Document is current

Any future updates will be listed below

Correction to: DEGRO statement on the KEYNOTE-689 trial: Perioperative immunotherapy in combination with adjuvant (chemo-)radiotherapy for resectable locally advanced head and neck cancers

Crossref DOI link: https://doi.org/10.1007/s00066-026-02534-z

Published Online: 2026-04-24

Published Print: 2026-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark